KMT2A
Onco
Daily
Twitter
Facebook
Youtube
RSS Feed
Linkedin
Facebook
RSS
Twitter
Youtube
Linkedin
July, 2024
July 2024
M
T
W
T
F
S
S
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
« Jun
KMT2A
Jun 14, 2024, 01:58 |
Blog
Sawyer Bawek: Our case report on “Acute Leukemia with KMT2A rearrangement:A Master of disguise”
Sawyer Bawek, UB IM Health Equity Committee Chair, shared on X/Twitter: "Our case report 'Acute Leukemia…
Apr 16, 2024, 01:37 |
Insight
Talha Badar: A brief overview on MLL gene re-arranged AL in this thread
Talha Badar, Hematologist/Oncologist at Mayo Clinic, shared a thread on X/Twitter: "Weekend review: MLL- rearrange…
Feb 13, 2024, 08:00 |
Blog
Talha Badar: Brief review focusing on VEN and HMA triplets in AML
Talha Badar, Hematologist/Oncologist at Mayo Clinic in Jacksonville, Florida, shared a thread on X/Twitter: "Weekend…
Jan 10, 2024, 18:21 |
Blog
Top Precision Oncology articles of 2023 by Vivek Subbiah
Vivek Subbiah shared on X/Twitter: "By popular demand delighted to share the 'Top Precision Oncology…
All:
4
Posts:
1 - 10
Eliot Levitt: The Yvonne Awards demonstrate something that it doesn't hurt to be reminded of
New data from the NEST clinical trial was presented at ESMOGI24 - Agenus
Zainab Shinkafi-Bagudu's latest commentary on Cervical Cancer Elimination Forum
New Paper Alert! Amivantamab-Lazertinib Improves Outcomes in High-Risk EGFR-Mutant NSCLC Subgroups: MARIPOSA Study Results
Learn more about overcoming barriers to immunotherapy for microsatellite stable colorectal cancer
Facebook
RSS Feed
Twitter
Linkedin
Youtube